$ParkwayLife Reit(C2PU.SG)

🦎 Iggy's Forensic File: Parkway Life REIT (SGX: C2PU) The social media cheer squad hails Parkway Life REIT as a "set-it-and-forget-it healthcare yield machine," flaunting a ~5% forward yield backed by Japan and France nursing homes and Singapore hospital master leases. But the FY2025 business update unearths a forensic mismatch: Q4 DPU plunged 4.6% QoQ to 3.73 Singapore cents, even as full-year DPU edged up 2.6% to about 15.29 cents on acquisition-driven revenue growth.

Gross revenue climbed 7.6% to S$156.3 million for the year, with NPI up 7.9% to S$147.2 million, but that Q4 stumble stems from trust expenses and finance costs ballooning faster than organic rent step-ups — reminiscent of a kopitiam uncle's utility bills spiking while customer traffic holds steady.

Singapore hospitals, the 65% revenue anchor under a 20.4-year master lease to Parkway Hospitals Singapore (an IHH arm), delivered fixed 2-3% escalations through FY2025, now pivoting to CPI-linked from FY2026 with downside protection.

Yet gearing sits at a comfy 33.4% (down from 35.8%), with interest coverage a robust 8.6x and no refinancing until late 2026 — a fortress sheet indeed.

The catch? Tenant concentration risk looms large at 60.8% from PHS; any IHH wobble could crimp that "guaranteed" stream like an MRT line shutdown mid-commute.

Sovereign Insight: At 1.58x P/B and ~5% yield, downside protection feels solid versus permanent loss, but the spread over CPF SA's 4.0% floor — a razor-thin ~100bps — barely compensates for FX decay in yen assets, acquisition integration drag, and that telltale Q4 DPU dip.

This is defensive bunker-grade stability, not explosive growth; true margin of safety hinges on CPI rent kicking in without hiccups before committing retiree coffee money.